儿童伤害预防的历史和成功
Brian Eichner1, Leticia Manning Ryan2
1Department of Pediatrics, Duke University Medical Center, 2301 Erwin Road, T901/Children's Health Center, Durham, NC 27705, USA.
Pediatric clinics of North America
|November 5, 2025
概括
儿科医生通过倡导和合作,在预防无意伤害方面发挥着至关重要的作用. 本综述强调了关键的历史努力和工具,这些努力和工具促进了伤害预防策略的发展.
科学领域:
- 公共卫生 公共卫生
- 儿科 儿科 儿科
- 伤害预防 预防伤害
背景情况:
- 预防无意伤害是儿科医生的核心责任.
- 成功的预防工作往往涉及到宣传,推广和多学科合作.
- 历史背景对于理解伤害预防的演变至关重要.
研究的目的:
- 总结在无意伤害预防中关键的历史事件.
- 确定关键的个人和工具,以推进预防策略.
- 提供一个代表性样本的努力,以告知未来的倡议.
主要方法:
- 历史回顾和关键事件和人物的综合.
- 对成功的初级和二级伤害预防策略的分析.
- 文献审查侧重于宣传,外展和合作.
主要成果:
- 记录了许多成功的伤害预防工作.
- 倡导,外展和多学科合作是成功干预中经常出现的主题.
- 特定的个人和工具对进步做出了重大贡献.
结论:
- 持续的儿科医生参与对于有效的伤害预防至关重要.
- 从历史上的成功中吸取教训可以指导未来的预防策略.
- 多方面的方法在减少无意伤害方面最有效.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Preventive Healthcare Services
1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239


